- List
- By Topic
- On Map
- Search Details

"RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Recruiting, Not yet recruiting, Available Studies | "Genital Diseases, Female"
Need help? See RSS Feeds
Choose a feed type:

"RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Recruiting, Not yet recruiting, Available Studies | "Genital Diseases, Female" (7 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03078400 | Recruiting | Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
18 | Female | 18 Years and older (Adult, Senior) | NCT03078400 | SPL-006 | March 10, 2017 | November 30, 2018 | December 31, 2018 | March 13, 2017 | June 16, 2017 |
|
||
2 | NCT03428802 | Recruiting | Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability |
|
|
Interventional | Phase 2 |
|
Other / NIH |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT03428802 | 051709 NCI-2018-00115 Pro20170001392 P30CA072720 |
March 8, 2018 | October 2, 2020 | October 2, 2020 | February 12, 2018 | March 23, 2018 |
|
||
3 | NCT03112668 | Recruiting | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT03112668 | 131604 NCI-2017-00445 Pro20170000115 P30CA072720 |
December 6, 2017 | May 2019 | May 2019 | April 13, 2017 | February 7, 2018 |
|
||
4 | NCT03311867 | Recruiting | Prolene Versus Ethibond for Cervical Cerclage |
|
|
Interventional | Not Applicable |
|
Other |
|
|
30 | Female | 18 Years and older (Adult, Senior) | NCT03311867 | PECC | PECC | August 1, 2017 | December 2018 | December 2018 | October 17, 2017 | October 17, 2017 |
|
|
5 | NCT02465060 | Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
6452 | All | 18 Years and older (Adult, Senior) | NCT02465060 | NCI-2015-00054 EAY131 U10CA180820 U24CA196172 |
August 12, 2015 | June 30, 2022 | June 8, 2015 | April 23, 2018 |
|
|||
6 | NCT01366144 | Recruiting | Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction |
|
|
Interventional | Phase 1 |
|
NIH / Industry |
|
|
276 | All | 18 Years and older (Adult, Senior) | NCT01366144 | NCI-2011-02500 UPCI 10-115 CDR0000700997 UPCI-10-115 8808 N01CM00100 P30CA047904 U01CA062490 U01CA062502 U01CA062505 U01CA069856 U01CA070095 U01CA099168 UM1CA186690 UM1CA186691 UM1CA186709 UM1CA186717 |
June 20, 2011 | July 31, 2017 | June 3, 2011 | July 26, 2017 |
|
|||
7 | NCT00719303 | Recruiting | Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
|
|
Interventional | Phase 3 |
|
Other / NIH |
|
|
1070 | Female | 18 Years and older (Adult, Senior) | NCT00719303 | GOG-0225 NCI-2009-00595 CDR0000594600 U10CA101165 U10CA180830 UG1CA189867 |
June 18, 2012 | December 31, 2020 | July 21, 2008 | February 16, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.